Ipamorelin

Description

Overview

Ipamorelin is a synthetic pentapeptide agonist of the growth hormone secretagogue receptor (GHS-R1a), originally designed as a selective ghrelin mimetic. It stimulates growth hormone (GH) release from the pituitary with minimal effect on other hormones such as ACTH, prolactin, FSH, LH, TSH or cortisol.

It has gained interest in laboratory research for applications in metabolism, body composition, bone health, and growth hormone axis modulation.

Product Details

• Peptide Type: GH secretagogue (ghrelin receptor agonist)
• Typical Sequence / Structure: Aib-His-D-2Nal-D-Phe-Lys (approximate)
• Molecular Formula / Weight: C₃₈H₄₉N₉O₅ (MW ~711.868 g/mol)
• Research Status: Provided as research-grade material only. Not approved for human or veterinary use.
• CAS Number: 170851-70-4

Research Applications

• GH Axis Studies: Facilitates investigation into the mechanisms of GH release, pulsatility, receptor selectivity, and downstream IGF-1/insulin signalling.
• Body Composition & Metabolism: Used in models exploring lean mass increase, fat mass reduction, bone density support, and modulation of adipose tissue via GH-mediated pathways.
• Peptide Design & Selectivity Research: Due to its high receptor specificity, ipamorelin serves as a model for studying peptide-receptor interactions, secretagogue development, and avoidance of off-target endocrine effects.

Usage & Safety

This product is intended for laboratory research use only. It is not approved for human or veterinary use, and should not be used for therapeutic, diagnostic or cosmetic applications. Handle with appropriate laboratory safety protocols and store under recommended peptide preservation conditions (dry, stable, protected from light).

Disclaimer

All information provided is for educational and scientific research purposes only. This material is not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary consumption.